BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1594825)

  • 21. Management of isoimmunized pregnancy by use of intravascular techniques.
    Barss VA; Benacerraf BR; Frigoletto FD; Greene MF; Penso C; Saltzman DH; Nadel A; Heffner LJ; Scherl JE; Doubilet PM
    Am J Obstet Gynecol; 1988 Oct; 159(4):932-7. PubMed ID: 3177548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rh alloimmunization].
    Boda D; Pataki L
    Orv Hetil; 1996 Nov; 137(44):2485. PubMed ID: 9026764
    [No Abstract]   [Full Text] [Related]  

  • 23. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rh disease: intravascular fetal blood transfusion by cordocentesis.
    Nicolaides KH; Soothill PW; Rodeck CH; Clewell W
    Fetal Ther; 1986; 1(4):185-92. PubMed ID: 3136620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: how much to transfuse?
    Plecas DV; Chitkara U; Berkowitz GS; Lapinski RH; Alvarez M; Berkowitz RL
    Obstet Gynecol; 1990 Jun; 75(6):965-9. PubMed ID: 2342745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early intrauterine transfusion in severe red blood cell alloimmunization.
    Yinon Y; Visser J; Kelly EN; Windrim R; Amsalem H; Seaward PG; Ryan G
    Ultrasound Obstet Gynecol; 2010 Nov; 36(5):601-6. PubMed ID: 20509139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of severe rhesus isoimmunization by repeated transfusions in utero].
    Lemaire B; Michaud P; Tescher M
    Rev Fr Gynecol Obstet; 1992 Dec; 87(12):587-90. PubMed ID: 1485075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of sonography in assessing severity of fetal anemia in Rh- and Kell-isoimmunized pregnancies.
    Chitkara U; Wilkins I; Lynch L; Mehalek K; Berkowitz RL
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):393-8. PubMed ID: 3126469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal immunity to red cell antigens and fetal transfusion.
    Gibble JW; Ness PM
    Clin Lab Med; 1992 Sep; 12(3):553-76. PubMed ID: 1521427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of fetal anemia due to isoimmunization.
    Plöckinger B; Strümpflen I; Deutinger J; Bernaschek G
    Arch Gynecol Obstet; 1994; 255(4):195-200. PubMed ID: 7695366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrauterine transfusion for rhesus alloimmunization elevates fetal beta2-microglobulin levels.
    Radunovic N; Kuczynski E; Funai EF; Nastic D; Di Renzo GC; Lockwood CJ
    J Matern Fetal Neonatal Med; 2003 Apr; 13(4):246-9. PubMed ID: 12854925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful therapy in severe alloimmunization during pregnancy].
    Gottvall T; Selbing A
    Lakartidningen; 1992 Mar; 89(12):968-9. PubMed ID: 1552792
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversion of the Ballantyne syndrome despite fetal hydrops persistence.
    Lobato G; Nakamura-Pereira M
    Fetal Diagn Ther; 2008; 24(4):474-7. PubMed ID: 19047795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prenatal treatment of severe fetomaternal blood group incompatibilities].
    Brossard Y; Chavinié J; Poissonnier MH
    Rev Prat; 1984 Dec; 34(59):3309-14. PubMed ID: 6441239
    [No Abstract]   [Full Text] [Related]  

  • 39. Intrauterine treatment of severe fetal erythroblastosis: intravascular transfusion with ultrasonic guidance.
    Keckstein G; Stoz F; Tschürtz S; Terinde R; Jonatha WD; Lauritzen C
    J Perinat Med; 1989; 17(5):341-9. PubMed ID: 2696779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization.
    Poissonnier MH; Picone O; Brossard Y; Lepercq J
    Fetal Diagn Ther; 2003; 18(6):467-71. PubMed ID: 14564122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.